StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
BSXBOSTON SCIENTIFIC CORP
stockpulse.co.kr
NYSE
$45.60▼ 0.11%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $67.78BShares out 14.900M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

17
  • 10.7Pre-market26.10.07 19:11
    8-KKey event#●●●

    BOSTON SCIENTIFIC CORP

    Boston Scientific has appointed Joe Fitzgerald as the new Chief Operating Officer, effective January 1, 2027, and will reorganize into three reportable segments—Interventional Therapies, Rhythm Solutions, and MedSurg—to enhance operational efficiency. Additionally, the company announced that Mark Bickel will become the new Chief Accounting Officer, effective March 1, 2027.…more

    $45.60-0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.23Pre-market26.09.23 19:01
    8-KKey event

    BOSTON SCIENTIFIC CORP

    Arthur C. Butcher, Executive Vice President and Group President of MedSurg and Asia Pacific at Boston Scientific, will retire effective January 1, 2027. He will continue to serve as a senior advisor until February 26, 2027, maintaining his current annual base salary of $780,000.…more

    $45.60-0.11%vs prev close
    View filingShare
  • 9.8Pre-market26.09.08 19:15
    8-KKey event

    BOSTON SCIENTIFIC CORP

    Boston Scientific experienced a cybersecurity incident on August 25, 2026, which disrupted global operations and led the company to determine that it is unlikely to meet its previously provided net sales growth and adjusted EPS guidance for the third quarter and full year 2026. While distribution and manufacturing operations have been substantially restored, the company expects the incident to have a material impact on its 2026 financial results.…more

    $45.60-0.11%vs prev close
    View filingShare

16 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 3d agoPre-market26.10.21 21:13
    Bullish#●●●

    Belo Sun Mining Faces Temporary License Suspension for Gold Project

    The Brazilian Supreme Court has temporarily suspended the installation license for Belo Sun's Volta Grande Gold Project pending the outcome of a settlement hearing. The project remains subject to judicial approval, maintaining uncertainty regarding its development timeline.…more

    $45.60-0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 10.7Pre-market26.10.07 19:05

    ●●●●●●●● ●●●●● ●●●●●●

    Boston Scientific has appointed Joseph M. Fitzgerald, currently the group president of Cardiovascular, as its new COO effective January 1, 2027. Fitzgerald has been instrumental in driving the company's portfolio growth and innovation within the cardiovascular sector.…more

    $45.60-0.11%vs prev close
    ShareBenzinga
  • 9.28Regular26.09.29 02:42

    ●●●●●●●● ●●●●● ●●●●●●

    Boston Scientific is recalling all Imager II Angiographic Catheters and permanently discontinuing the product line due to a manufacturing defect that poses safety risks. While the company is taking proactive measures, the recall and product discontinuation may impact future revenue.…more

    $45.60-0.11%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →